Aurobindo Pharma Ltd. (AUROPHARMA) - Financials, balance sheet (quarterly)

1,216.90002 INR

3.1

0.25%

Last update May 15, 3:29 PM IST

Market closed

Day range

1,216.90002

1,209.69995

1,229.69995

Previous close

1,220

Open

1,229.69995

Access this stock data via API

Aurobindo Pharma Ltd.

1,216.90

3.10

0.25%

Financials

Balance sheet

Fiscal date	Sep 2024	Mar 2024	Sep 2023	Mar 2023
Total assets	480.9B	450.7B	439.2B	398.9B
Current assets	262.3B	242.1B	235.6B	215.5B
Cash	—	13.8B	—	18.0B
Cash equivalents	—	20.1B	—	25.9B
Cash and cash equivalents	39.0B	33.9B	41.3B	44.0B
Other short term investments	36.2B	29.3B	33.0B	18.3B
Accounts receivable	53.9B	48.2B	46.4B	44.7B
Other receivables	138.8M	5.3B	132.6M	5.5B
Inventory	104.3B	98.1B	92.8B	85.1B
Prepaid assets	—	22.9B	—	16.8B
Restricted cash	—	37.1M	—	115.7M
Assets held for sale	0	4.3B	29.1M	857.6M
Hedging assets	—	34.5M	—	191.4M
Other current assets	28.7B	25.4B	21.6B	18.7B
Non current assets	218.7B	208.7B	203.7B	183.4B
Properties	114.3B	115.5B	78.7B	80.0B
Land and improvements	—	9.8B	—	9.5B
Machinery furniture equipment	—	120.2B	—	90.1B
Construction in progress	35.0B	28.7B	58.0B	48.1B
Leases	—	—	—	—
Accumulated depreciation	—	-63.7B	—	-55.6B
Goodwill	46.4B	46.7B	44.3B	45.2B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	33.8B	34.8B	32.4B	33.3B
Investments and advances	—	—	—	—
Other non current assets	2.6B	2.3B	9.5B	45.3M
Total liabilities	172.1B	152.2B	157.3B	130.4B
Current liabilities	143.4B	122.0B	130.1B	114.9B
Accounts payable	44.3B	44.5B	45.1B	38.7B
Accrued expenses	—	—	—	—
Short term debt	62.4B	42.6B	46.2B	43.5B
Deferred revenue	—	—	—	—
Tax payable	3.6B	2.5B	3.5B	2.1B
Pensions	—	2.6B	—	2.0B
Other current liabilities	6.7B	2.8B	10.8B	2.2B
Non current liabilities	28.7B	30.2B	27.2B	15.4B
Long term provisions	2.5B	2.3B	2.1B	1.7B
Long term debt	21.9B	23.9B	20.3B	9.4B
Provision for risks and charges	—	1.2M	—	290.4M
Deferred liabilities	3.7B	3.6B	4.3B	3.9B
Derivative product liabilities	—	—	—	—
Other non current liabilities	456.1M	364.7M	270.9M	-15.2B
Shareholders equity
Common stock	580.8M	585.9M	585.9M	585.9M
Retained earnings	—	268.0B	—	240.1B
Other shareholders equity	—	—	—	—
Total shareholders equity	308.8B	298.5B	281.9B	268.5B
Additional paid in capital	—	5.3B	—	4.3B
Treasury stock	—	—	—	—
Minority interest	65.7M	80M	57.1M	120M